ZYDUS LIFESCIENCES
|
ZYDUS LIFESCIENCES Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit Before Tax | ₹4,838 Cr | ₹2,583 Cr | ₹5,232 Cr | ₹2,285 Cr | ₹1,495 Cr |
Adjustment | ₹547 Cr | ₹934 Cr | ₹-2,117 Cr | ₹1,163 Cr | ₹1,474 Cr |
Changes In working Capital | ₹-871 Cr | ₹-236 Cr | ₹-336 Cr | ₹191 Cr | ₹264 Cr |
Cash Flow after changes in Working Capital | ₹4,514 Cr | ₹3,281 Cr | ₹2,779 Cr | ₹3,639 Cr | ₹3,234 Cr |
Cash Flow from Operating Activities | ₹3,228 Cr | ₹2,689 Cr | ₹2,105 Cr | ₹3,294 Cr | ₹2,932 Cr |
Cash Flow from Investing Activities | ₹-1,475 Cr | ₹1,535 Cr | ₹-1,000 Cr | ₹-725 Cr | ₹-1,012 Cr |
Cash Flow from Financing Activities | ₹-1,810 Cr | ₹-4,400 Cr | ₹-868 Cr | ₹-2,548 Cr | ₹-1,528 Cr |
Net Cash Inflow / Outflow | ₹-58 Cr | ₹-177 Cr | ₹236 Cr | ₹22 Cr | ₹391 Cr |
Opening Cash & Cash Equivalents | ₹488 Cr | ₹658 Cr | ₹888 Cr | ₹1,178 Cr | ₹779 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | ₹6.00 Cr | - | ₹-26 Cr | ₹-108 Cr | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | ₹-23 Cr | ₹6.60 Cr | ₹8.60 Cr | ₹-4.20 Cr | ₹7.90 Cr |
Closing Cash & Cash Equivalent | ₹413 Cr | ₹488 Cr | ₹1,107 Cr | ₹1,087 Cr | ₹1,178 Cr |
Compare Cashflow Statement of peers of ZYDUS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZYDUS LIFESCIENCES | ₹98,829.0 Cr | 3.3% | -2% | 53.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,544.0 Cr | 2.8% | -2.7% | 50.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,865.0 Cr | 3.5% | 5.4% | 67.6% | Stock Analytics | |
CIPLA | ₹123,920.0 Cr | 2.9% | -1.2% | 25.5% | Stock Analytics | |
MANKIND PHARMA | ₹102,527.0 Cr | 0.1% | -4% | 37.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,224.0 Cr | 2.1% | -3.9% | 6.9% | Stock Analytics |
ZYDUS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | 3.3% |
-2% |
53.5% |
SENSEX | 1.1% |
1.1% |
22.2% |
You may also like the below Video Courses